ADVERTISEMENT

regulation

Medical Marijuana for Kids?
Aimee Swartz | Jul 17, 2013 | 4 min read
The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.
Week in Review, July 8–12
Jef Akst | Jul 12, 2013 | 4 min read
Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism
Opinion: Research, Restricted
David Nutt | Jul 8, 2013 | 4 min read
Are the international drug laws the worst impediment to scientific inquiry since the Catholic Church banned the telescope?
New Stem Cells Off Limits to Many
Dan Cossins | Jun 5, 2013 | 2 min read
Rules regarding the use of cells derived from human embryos will deny many US researchers the chance to study new stem-cell lines created by cloning.
FDA to Regulate Fecal Transplants
Dan Cossins | May 21, 2013 | 2 min read
From now on, US physicians and researchers will have to get approval from the FDA before they can perform a stool transplant.
How Safe Is Your Medicine Cabinet?
Megan Scudellari | May 1, 2013 | 7 min read
After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
The Rebirth of DIYbio
Jef Akst | Mar 1, 2013 | 3 min read
Do-it-yourself science is likely as old as science itself, driven by an inherent curiosity about the world around us.
Regulating Amateurs
Dustin T. Holloway | Mar 1, 2013 | 4 min read
How should the government ensure the safety and responsibility of do-it-yourself biologists?
DIYbio: Low Risk, High Potential
Todd Kuiken | Mar 1, 2013 | 3 min read
Citizen scientists can inspire innovation and advance science education—and they are proving adept at self-policing.
Drug Approvals Up
Dan Cossins | Dec 7, 2012 | 1 min read
The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.
 
Hurry Up, FDA
Jef Akst | Dec 6, 2012 | 2 min read
The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
Special Review for H5N1 Grants?
Jef Akst | Dec 4, 2012 | 2 min read
The National Institutes of Health reveals a controversial plan to regulate the funding of H5N1 research.
Stem Cell Treatment = Drug
Bob Grant | Jul 30, 2012 | 1 min read
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
Regulations for Biosimilars
Lisa A. Haile and Kimberly K. Egan | Jun 1, 2012 | 5 min read
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
White House Weighs in on H5N1
Jef Akst | Apr 18, 2012 | 1 min read
Science adviser John Holdren speaks out about how the Presidential Administration is handling the controversial research that rendered avian flu transmissible between ferrets.
Risky Research Review
Jef Akst | Mar 30, 2012 | 2 min read
A new policy will require federal agencies to perform a careful review of research involving 15 pathogens and toxins that could be used for bioterrorism, including H5N1.
A Call to Ban Synthetic Biology
Edyta Zielinska | Mar 15, 2012 | 1 min read
More than 100 environmental policy organizations call for greater oversight and regulation of synthetic biology.
Self-prescribing Patients?
Jef Akst | Mar 13, 2012 | 1 min read
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Opinion: No Objections to Nano?
Susanna Priest | Feb 3, 2012 | 4 min read
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
A Bill to Expedite Drug Production
Jef Akst | Feb 2, 2012 | 1 min read
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.
ADVERTISEMENT